000 | 01592 a2200517 4500 | ||
---|---|---|---|
005 | 20250511205056.0 | ||
264 | 0 | _c19920610 | |
008 | 199206s 0 0 eng d | ||
022 | _a0332-5652 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aHalstensen, A | |
245 | 0 | 0 |
_aSerum opsonins to serogroup B meningococci after disease and vaccination. _h[electronic resource] |
260 |
_bNIPH annals _cDec 1991 |
||
300 |
_a157-65; discussion 166-7 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAged, 80 and over |
650 | 0 | 4 | _aBacterial Capsules |
650 | 0 | 4 |
_aBacterial Outer Membrane Proteins _ximmunology |
650 | 0 | 4 |
_aBacterial Vaccines _xadministration & dosage |
650 | 0 | 4 | _aChild |
650 | 0 | 4 | _aChild, Preschool |
650 | 0 | 4 | _aClinical Trials as Topic |
650 | 0 | 4 | _aCross Reactions |
650 | 0 | 4 | _aDose-Response Relationship, Immunologic |
650 | 0 | 4 | _aEvaluation Studies as Topic |
650 | 0 | 4 | _aFlow Cytometry |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aInfant |
650 | 0 | 4 | _aLuminescent Measurements |
650 | 0 | 4 |
_aMeningococcal Infections _xblood |
650 | 0 | 4 | _aMeningococcal Vaccines |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aOpsonin Proteins _xblood |
650 | 0 | 4 |
_aPolysaccharides, Bacterial _ximmunology |
650 | 0 | 4 | _aSerotyping |
650 | 0 | 4 | _aTime Factors |
700 | 1 | _aLehmann, A K | |
700 | 1 | _aGuttormsen, H K | |
700 | 1 | _aVollset, S E | |
700 | 1 | _aBjune, G | |
700 | 1 | _aNaess, A | |
773 | 0 |
_tNIPH annals _gvol. 14 _gno. 2 _gp. 157-65; discussion 166-7 |
|
999 |
_c1818653 _d1818653 |